Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer

Figure 2

Dose-dependent plots for four of the representable drugs, that is, anisomycin, mefloquine, niclosamide, and trichostatin A (TSA).

(a)

(b)

(c)

(d)